Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Catherine GUILLOU

Catherine GUILLOU

Unversité de Paris-Saclay France

Larisa Klapshina

Larisa Klapshina

Nizhny Novgorod State University/IOMC RAS Russia

Fabio Marinelli

Fabio Marinelli

University of L’Aquila Italy

Francisco Alonso

Francisco Alonso

Universidad de Alicante Spain

Mark McLaughlin

Mark McLaughlin

Merck Sharp & Dohme (MSD) Dept. of Process Research and Development USA

Dorota Dobler

Dorota Dobler

University of Applied Sciences Germany

Shira Engelberg

Shira Engelberg

Israel Institute of Technology Israel

Vasiliki Daikopoulou

Vasiliki Daikopoulou

R.G.C.C. S.A. Greece

Pharmaceutical Chemistry-2020

About Conference


Pharmaceutical Chemistry 2020  is a global overview the Theme “Illuminate the Trends in Pharmaceutical Sciences”. It is a pavement for Pharmaceutical Chemistry experts and scientific professionals to explore the research challenges & current trends and unleash advanced strategies in the arena of Pharma and Chemistry research areas. Pharmaceutical Chemistry 2020 is a specially designed cluster conference and would lay a platform for  the interaction among specialists, directors, professors, faculties, experts and research fellows around the world reputed research institutes, universities and companies, agencies, association & societies. It aims in accelerating the scientific discoveries in the field of Pharma and Chemistry to exchange information on their latest research progress. We are glad to have your presence at ‘International Conference on Pharmaceutical Chemistry’ scheduled to be held during 17-18 August, 2020 at London, UK.  The organizing committee is gearing up for an exciting and informative event procuring plenary lectures, symposium, workshops on a variety of topics, poster presentations and various sessions for participants from all over the world. All the members of Pharmaceutical Chemistry -2020 organizing committee look forward to meet you at London, UK..

For more details please visit- https://pharmaceuticalchemistry.pharmaceuticalconferences.com/

 

Why Attend?

With all the Expert scientific people over the world focused on learning about Pharmaceutical Current and Novel trends and advanced strategies and Technologies emerging in Pharma and Chemistry research areas. This is a best globalised opportunity to reach the largest assemblage of participants from the Pharma and Chemistry community. We anticipate participants, renowned speakers, pharmacists/chemist and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community.

Pharmaceutical Chemistry 2020  is a 2-day event offering the Exhibition at venue to showcase the new and emerging technologies and Conduct presentations, distribute information, meet with potential scientists, make a splash with new drug developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing. World-renowned speakers, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Target Audience:

  • Eminent Scientific Professionals in Pharma and Chemistry
  • Faculty (Professors, Associate Professors, Asst. Professors)
  • Pharma and Chemistry Colleges & Training Institutes
  • Pharmaceutical and Chemistry Associations and Societies
  • Pharmaceutical Business Entrepreneurs
  • Manufacturing Pharmaceutical products Companies
  • Manufacturing Medical Devices Companies
  • Pharma and Chemistry Students
  • PhD Scholars, Graduates and Post Graduates
  • Directors, CEO’s of Organizations
  • Association, Association presidents and professionals
  • Noble laureates in Health Care and Medicine
  • Bio instruments Professionals
  • Bio-informatics Professionals
  • Research Institutes and members
  • CRO and DATA management Companies
  • Data Management Companies

 

Sessions and Tracks

Track 1: Pharmaceutical Formulations: Academic and Industry Perspective

Increasingly, medicines research is moving from ‘big Pharma’ to small biotech companies and start-ups. To succeed in this new environment, scientific skills are not enough employers and financiers also need to be confident that the people they are working with possess the entrepreneurial skills to grow and sustain a business effectively. Pharmaceutical formulation development enables development of robust and compliant formulations and resolve difficult challenges encountered during preclinical and clinical development.

  • Pharmaceutics and Drug Delivery

  • Pre Formulation & Formulation Aspects

  • Preformulation in Drug Development

  • Major Challenges in Drug Development

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 2: Pharmaceutical Research and Development

Research and Development can be defined as innovative and experimental work undertaken on a systematic basis to increase the stock of knowledge including search of new molecules, synthesis and modification of known molecules and some methods to increase production rate by adopting diverse techniques. Superior quality R&D work requires an excellent back up from what are called the support functions. These include analytical, information services and technology, intellectual property and regulatory affairs. These are some of the main considerations in Pharmaceutical Technology and for the development of new drug candidates. The management of these functions, especially the laboratory based analytical service, requires many of the skills associated with core R&D and will therefore not be treated separately in any detail, except to point out their relationship and role within the organization.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 3: Chemo genomics

Chemogenomics is an emergent discipline that combines the latest tools of genomics and chemistry and applies in the discovery of novel drug molecules thereby to target drug discovery. Because of the almost infinite number of drug-like organic molecules, this is an impossible task. Chemogenomics, on the other hand can be defined as the investigation of classes of compounds or related libraries. These compounds are meant to work against families of functionally related proteins in the protein structure. Chemogenomics also deals with the chemical-biological interactions and their systematic analysis. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

  • Biomolecules

  • Preparation of Natural products

  • Metal Complexes creation

  • Asymmetric synthesis

  • Organometallic chemistry

  • Nucleotide chemistry

  • Chemogenomics and Chemical Biology for Target Identification and Validation

  • Assemblies of macrolide-mimetics

  • Spiro– medium- and large(macro) heterocyclic systems

  • Isosteric replacements of amino acids, di-/tri-peptides

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 4: Solid-state pharmaceutical chemistry

Solid-state pharmaceutical chemistry envelops a wide scope of concentrates on pharmaceutical solids including (1) assurance of the physical properties of polymorphs and solvates, (2) physical changes among polymorphs and solvates, (3) chemical responses in the solid state, and (4) solid-solid responses which happen in pharmaceutical preparations. Recent advances in this field incorporate improved comprehension of crystallization processes, improved comprehension of the requirement for characterization of polymorphs and solvates for both control and administrative purposes, and a superior comprehension of the mechanisms of solid state degradations and solid-solid reactions.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 5: Pharmaceutical Organic Chemistry

Organic chemistry  is the scientific study of the structure, properties, composition, reactions, and synthesis of organic compounds that by definition contain carbon. Organic chemistry is the scientific study of the structure, properties, composition, reactions, and synthesis of organic compounds that by definition contain carbon. Pharmaceutical heavily relies on medical world as it centers around medicine and other health related compound. A pharmacist should have sufficient knowledge of organic chemistry as the basis of drug prescription.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 6: Pharmacovigilance

Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 7:  Drug Discovery Chemistry

The discovery of candidate drug targets is challenging, requiring the rapid development of techniques to identify the difference genomic profiling in disease and normal conditions, which will facilitate the understanding of the disease mechanism and the development of potential drugs for disease treatment. Medicinal chemistry has increasingly employed microarrays to identify both key target genes and gene networks that can regulate the effectiveness of drugs. As compared with all the other phases in drug discovery, this stage is complex by the fact that the identified drug target must mollify a variety of standards to permit development to the next step. For example, the target must be selectively present in the pathogen, i.e. medicinal chemistry along with coding genes of drug design target that are preserved across different pathogens and have no human homologs and therefore they represent striking target candidates for new broad-spectrum drugs. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

  • Fragment-Based Drug Discovery

  • Macrocyclics & Constrained Peptides

  • Biophysical Approaches for Drug Discovery

  • Small Molecules for Cancer Immunotherapy

  • Inflammation Inhibitors

  • Protein-Protein Interactions

  • GPCR-Targeted Drug Design

  • Blood-Brain Penetrate Inhibitors

  • Kinase Inhibitor Chemistry

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 8: Medicinal Chemistry Strategies

In the drug discovery and drug development of a new drug, different terms are assigned to the substances that are studied at different steps in the process. Only if a substance fulfils the requirements for a certain level is it subjected to testing on the next level. The process starts with a compound which is a chemical substance of defined chemical structure and purity. There are many strategies developed in Medicinal Chemistry in the recent years for the development of new drug candidates. Compounds that show specific binding properties and are active are referred to as ‘hits’ and are further validated; this includes verifying their chemical identity and purity and determining their binding properties in one or more secondary assays. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology. 

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 9: Pharma Medicinal Chemistry

Modern drug research and development (R&D) has experienced remarkable changes as technological and scientific developments in the past years have dramatically changed the pharmaceutical innovation process. Well-established strategies, such as high-throughput screening (HTS), have progressively been applied in association with novel techniques founded on genomics, molecular and structural biology and molecular modeling.

  • Targeted protein degradation / PROTACs

  • DNA Encoded Libraries

  • Hit-to-Lead Optimization

  • Predictive Toxicology – Improving Compound Safety

  • Optimizing Outsourcing Activities

  • Artificial Intelligence in Medicinal Chemistry

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 10: Integrating Medicinal Chemistry into the Drug Discovery Process

Traditionally, “drug delivery” was a specialization in pharmacy for formulations of drugs. However, it is natural that organic, medicinal, materials, and nano chemistry have now become deeply involved in the development of drug delivery systems. These approaches have led to the creation of drug conjugates that are new chemical entities. The use of functional carbon nanotubes as well as designed polymers as a vehicle for drug delivery is a novel approach to drug discoveryMedicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with designchemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs). The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 11: Pharmacokinetics and Pharmacodynamics in Drugs

Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.

Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and adverse effects. The effect of a drug present at the site of action is determined by that drug’s binding with a receptor.

  • Pharmacokinetic parameters

  • Pharmacodynamic parameters

  • Absorption of drugs

  • Distribution of drugs

  • Biotransformation/metabolism

  • Excretion of drugs

  • Pharmacodynamics

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 12:  Drug Design and Synthesis

The rational development of new drugs is a complex process involving a myriad of different disciplines. In nearly all of these, computational tools serve to guide the design decisions, ultimately speeding up and reducing the cost of development. Drug design and the synthesis of new drug molecules is one of the important aspect in medicinal chemistry and it is one of the keytopics discussed at Medicinal Chemistry Conferences. In the area of medicinal chemistry, computational methods are applied both to identify new starting points and to guide the further development of promising substances.

  • Frontiers in Catalysis

  • Aggressive Bond Disconnections in Total Synthesis

  • Chemical Probes for Characterizing Biology

  • Synthetic Biology for Natural Products

  • Advances in Drug Discovery

  • Natural Product Discovery and Biosynthesis

  • Combining Synthesis and Biosynthesis to Construct Complex Molecules

  • New Directions in Antibiotic Discovery and Development

  • Accessing Complex Molecules

  • Structure-biodegradability relationship

  • Diversity-Oriented Synthesis

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 13: Organic Chemistry

The synthesis of each molecule was first carried out on a small scale (probably milligrams) in the laboratory, followed much later by development of safe, efficient, and scalable methods to provide kilograms of active pharmaceutical ingredient (API) that was incorporated into dosage forms for administration to patients. It is critical to point out that an early step in the complex process of drug discovery was the synthesis of a molecule that tested a hypothesis faced by the project team. This required a medicinal chemist to use organic chemistry training and experience to conceive of a compound and then employ appropriate reactions to furnish the desired target and synthesize a suitable number of derivatives to optimize the spectrum of properties associated with drug like candidates. The current meeting of chemistry conferences will be a multinational gathering and present majorareas such as Medicinal Chemistry, Pharmaceutical Sciences, Pharmaceutical Chemistry, Pharmaceutical Technology.

  • Medicinal chemistry

  • Drug discovery

  • Total synthesis of natural products

  • Heterocyclic compounds

  • Synthesis and functional properties of molecules

  • Asymmetric synthesis

  • Green chemistry

  • New reagents, strategies, catalysts and concepts for organic synthesis

  • Mechanistic organic chemistry

  • Computational chemistry

  • Supramolecular chemistry

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 14: Nano medicine and Biomedical Applications

Nano medicine is simply the nanotechnology applications in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behavior of drug substances and in drug delivery. Today, nanomedicine conferences are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced delivery systems, new therapies, and in vivo imaging.

  • Scope of nanomedicine

  • Novel drugs to nano drugs

  • Nanomedicine for other disease

  • Nanomedicine for gastrointestinal tract (GI) diseases

  • Nanomedicine for CNS

  • Nanomedicine for blood disorders

  • Nanomedicine for lung diseases

  • Nanomedicine for cardiovascular diseases

  • Future aspects of nanomedicine

  • Nanodrugs for herbal medicines and cosmetics

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 15: Chemical Synthesis and Catalysis

From drug synthesis to quality control (QC) monitoring of over-the-counter medications, metals are found in all phases of the drug development process. Many metal-based products are used as imaging agents, and metals are used in the synthesis of drug substances, as excipients in tablets, capsules and liquids. In addition, trace metals can arise from the equipment used to manufacture a drug substance or compound. Because of the prevalence of metals associated with the drug development and manufacturing process, various atomic and emission-based techniques are often used to help fully characterize pharmaceutical products.

  • Organocatalysis

  • Flow-chemistry approaches to the synthesis of key targets

  • Applications of organometallic compounds in synthesis and catalysis

  • Stereoselective synthesis

  • Synthesis and property of functional molecules and organic materials

  • Sustainable and Green synthetic and catalytic methods

  • Process development of key pharmaceutical targets

  • Synthesis in Medicinal chemistry and chemical biology

  • Biocatalysis in synthesis

  • Computational tools for synthesis and catalysis

  • Polymer synthesis

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 16: Pharmacovigilance and Cosmetovigilance

Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical product. The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation). Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction.

Cosmetovigilance is the ongoing and systematic monitoring of the safety of cosmetics in terms of human health. The aim is to detect adverse effects of cosmetic products, and to prevent adverse effects by taking appropriate measures. Regulations for cosmetic products primarily address the safety of products that may be used by large populations of healthy consumers. The identification and analysis of adverse effects related to cosmetic products is a process that is currently still, to a large extent, industry driven. It is the responsibility of manufacturers to determine that products and ingredients are safe before they are marketed, and then to collect reports of adverse reactions.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 17: Bioorganic Chemistry

Broadly defined, the discipline of bioorganic chemistry seeks an understanding of biological processes through the tools and principles of organic chemistry. Bioorganic chemistry can be defined as a multifaceted field which has its historical roots in detailed mechanistic studies of enzyme along with coenzyme models. The field of bioorganic chemistry currently focuses more on the trending topics like molecular recognition, encompassing mechanistic investigations of enzymes themselves, drug design. It also deals with study of drug action, problems in biosynthesis, protein engineeringmolecular evolution, supramolecular chemistry, and many other allied subjects.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 18: Pharmacognosy and Phytochemistry

Phytochemistry is in the study of phytochemicals in plants and other natural sources. Phytochemicals are chemicals derived from plants. In other words the terms are often used to describe the large number of primary and secondary metabolic compounds found in plants. Phytochemicals have properties such as protection against insect attacks and diseases. They also exhibit a number of protective functions for human beings also.

  • Traditional Medicine

  • Clinical Pharmacognosy

  • Aromatic Medicinal Plants

  • Marine Drugs

  • Applied Plant Sciences

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences |Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 19: Medico Marketing

Medico-Marketing focusses on exchange of drug information among drug manufacturing company and the recommending doctor, Nurse, Pharmacist or with the end user. The intention behind this data exchange is to describe the Pharmaceutical Company’s products and how it will benefit the patient community in diagnosis or management of the human ailments.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 20: Medicinal Chemistry: Physical Properties and Drug Design

The recent changes in the way that synthetic chemistry is practiced in this environment center around new scientific advances in synthetic techniques and modern technologies for rational drug designcombinatorial chemistry, automated synthesis, and compound purification and identification. In addition, with the beginning of high-throughput screening, we are now dealing with many targets being screened and many other hits that are being evaluated. However, success in the discovery of new drug molecules requires more and more skilled medicinal chemists to make the accurate choices with the insights gathered from interactions with computational chemists along with the insights from structural biologists, about which “hits” are likely to play out as true “lead” structures that will meet the plethora of hurdles that any drug candidate must surmount.

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

Track 21: Recent Advances in Pharmaceutical Technology

The pharmaceutical industry channels an important proportion of total research in most developed countries. In Europe, for example, it represents about 13% of total R&D. In recent years, pharmaceutical companies have been accused of devoting their resources mainly to minor improvements over existing medications that require short clinical trials and have a small risk of not being approved. The support functions were an integral part of a large company’s R&D function but nowadays they are most likely to be outsourced under contract to external organizations specializing in a specific service, especially if these activities are not seen to offer a competitive advantage to the company. Medicinal chemistry and pharmaceutical chemistry are disciplines at the intersection of chemistry, especially synthetic organic chemistry, and pharmacology and various other biological specialties, where they are involved with designchemical synthesis and development for market of pharmaceutical agents, or bio-active molecules (drugs).

Keywords: Pharmaceutical sciences Conferences | Pharmaceutical Conferences | Pharmaceutical ChemistryDrug Discovery Conferences | Drug designing Conferences | Drug delivery Conferences | Nanomedicine Conferences | Pharmacology Conferences | Pharmacy Conferences | Bio Pharmaceutical Conferences | Pharmaceutics Conferences | Pharmaceutical Manufacturing Conferences | Medical Conferences | Pharmaceutical Conferences 2020 | Pharma Conferences | International Pharmaceutics Conferences | global pharmaceutical Conferences | Pharmaceutical Conferences USA | Pharmaceutical Conferences Asia | Pharmaceutical Conferences Europe | Pharmaceutical Conferences Middle East | Medical Conferences Asia | USA Medical Conferences | Medical Conferences Europe | International Medical Conferences | London Conferences | Conference in UK

Societies: Society for Clinical Trials, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM),  International Society of Pharmacovigilance (ISOP), Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), European Association for Clinical Pharmacology and Therapeutics (EACPT), International Pharmaceutical Federation (FIP)

 

Market Analysis

There has been an upsurge in the usage of advanced technologies, such as high throughput, bioinformatics and combinatorial chemistry for better drug candidate identification. Drug discovery has evolved significantly with emerging technologies, helping the process to become more refined, accurate, and less time consuming. Due to automation, multi-detector readers, imaging hardware and software, high-throughput screening is one of the most widely used drug discovery technologies.

In recent years, there has been a rising demand for specialty medicines that is expected to ultimately influence the small molecule drug discovery market in a positive manner, as most of the specialty medicines are small molecules.

The gradual rise in the healthcare expenditure regionally helps the new pharmaceutical technology advancement. Although with high expenditure, there is a need for redirecting the resources, the transition toward better usability of healthcare expenditure for drug development is under progress.

Scope and Importance of Pharmaceutical Sciences:

The scope of pharmacy follow includes combining and dispensing medications, and it conjointly associated with a lot of fashionable services like patient care, clinical services, reviewing medications for safety and effectivity, and conjointly providing and gaining the drug data.

A Glance at Market of Pharmaceutical Sciences:

The power of worldwide pharmaceutical company has been growing over the past year, in keeping with the annual survey conducted Worldwide. Throughout the last 10 to fifteen years, deals among the worldwide Nutrition supplements market have seen AN exceptional spike. The pharmaceutical business is a crucial player in UK. In 2017, the annual turnover of pharmaceutical product wholesalers within the United Kingdom was over forty two billion British pounds, whereas the gross sales from the retail sales of pharmaceutical product amounted to virtually 5 billion British pounds in 2015. The cost within the producing of pharmaceutical product came up to over four billion in 2019.

Growth potential

India (7.16), the U.S. (7.04) and China (6.81) are again the countries highlighted as having the fastest growth potential. Respondents viewed their high growth domestic markets and expanding manufacturing exports as a success. Germany was seen as Europe’s key growth market. The biggest movers in terms of growth potential in comparison to last year were the UK, boosting its score by 12.72%, followed by Italy (+10.94%), the U.S. (+10.63%) and Japan (+9.56%).

 

To Collaborate Scientific Professionals around the World

Conference Date August 17-18, 2020

Speaker Opportunity

Supported By

Journal of Clinical & Experimental Pharmacology Medicinal Chemistry Clinical Pharmacology & Biopharmaceutics

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by